Cardiol Therapeutics Bolsa (NASDAQ: CRDL)

Cardiol Therapeutics (NASDAQ:CRDL) Bolsa

Cardiol Therapeutics

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Cardiol Therapeutics Inc. - Class A Common Shares

Cardiol Therapeutics Inc

News

GPUS

Hyperscale Data Reports $11.2M YTD Bitcoin Mining Revenue, Including $1.5M In June 2025; 18,200 Antminers Now Operational Across Sites

BranchOut Food Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOF#NASDAQ">BOF</a>), a pioneer in advanced dehydration technology and clean-label snacks, is proud to announce a major national expansion with the nation's largest retailer. Following the exceptional performance of its innovative Brussels Sprout Crisps, BranchOut has been awarded a nationwide rollout of the product into 3,945 stores, up from the 2024 launch in approximately half of their stores.
This milestone underscores the strength of BranchOut's ability to deliver true innovation and the rising demand for its unique snack offerings. The Brussels Sprout Crisps, the first of their kind in the market, launched last year to overwhelming consumer response. Their strong velocity and category-defining nature helped solidify their place as a standout new item.
In addition to the expanded distribution of the Brussels Sprouts, BranchOut will also debut its newest innovation: Sweet Potato Sticks Topped with Cinnamon, launching into 1,952 stores, representing approximately 50% of the retailer's footprint. These new snacks offer a lightly sweet, crunchy experience and are crafted using BranchOut's proprietary GentleDry&#x2122; technology to preserve the vibrant color, flavor, and nutrition of the sweet potatoes.

BranchOut Food Expands to Nearly 4,000 Stores as Brussels Sprout Crisps Go National

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk&#8216;s announcement of a new political party has had a significant impact on the electric vehicle maker. The company&#8217;s stock plummeted by 6.79% on Monday, resulting in a loss of over $68 billion in market capitalization.
What Happened: The stock drop came after Musk announced plans to launch a new political party, raising investor concerns about possible effects on <a href="https://www.benzinga.com/markets/tech/25/07/46267743/tesla-shares-fall-over-5-in-overnight-trading-as-elon-musk-jumps-back-into-politics">Tesla&#8217;s brand and business</a>, according to market data. 
Musk revealed his plan to establish the &#8220;America Party,&#8221; which would focus on a few Senate seats and House districts. This announcement has intensified worries about Musk&#8217;s increasing involvement in politics, a trend that has previously unsettled investors.
President Donald Trump&#8217;s initial praise for Musk&#8217;s political activities has turned into criticism, with the two clashing over various policy issues. Trump has <a href="https://truthsocial.com/@realDonaldTrump/posts/114808616176041421">labeled</a> Musk&#8217;s party formation as &#8220;ridiculous&#8221; and accused him of going &#8220;completely off the rails.&#8221;
See Also: <a href="https://www.benzinga.com/crypto/25/07/46267760/cathie-wood-questions-big-movement-in-old-bitcoin-part-of-a-government-settlement-deal">Cathie Wood Questions Big Movement In Old Bitcoin: &#8216;Part Of A Government Settlement Deal?&#8217;</a>
Why It Matters: Musk&#8217;s return to politics has <a href="https://www.benzinga.com/news/politics/25/07/46267326/elon-musks-america-party-is-a-move-in-the-opposite-direction-says-dan-ives-analyst-gary-black-says-difficult-to-predict-impact-on-tesla-brand-short-term">drawn criticism</a> from industry veterans. Ross Gerber, co-founder of Gerber Kawasaki, and Dan Ives, from Wedbush Securities, have <a href="https://www.benzinga.com/markets/tech/25/07/46288776/ross-gerber-slams-joke-tesla-board-as-elon-musk-returns-to-politics-dan-ives-says-musk-cannot-start-own-political-party-and-remain-ceo">criticized Musk&#8217;s political</a> re-entry.
They have also questioned Tesla&#8217;s Board of Directors as the company&#8217;s stock declined by almost 7% in a single session on Monday.
Moreover, Tesla&#8217;s stock has been affected by other factors, including a <a href="https://www.benzinga.com/markets/asia/25/07/46289899/tesla-china-sales-plunge-over-75-in-first-week-of-july-despite-strong-q2-deliveries">sharp drop in sales in the Chinese domestic car market</a> during the first week of July, despite strong second-quarter deliveries. This has added to the challenges facing the company.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46282616/disbelief-is-the-fuel-for-this-bull-market-but-how-much-fuel-is-left">Disbelief Is The Fuel For This Bull Market, But How Much Fuel Is Left?</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Equities

Politics

Global

Markets

TSLA

Tesla Tanks $68 Billion As Elon Musk Unveils 'America Party'—Investors Rattle Over Political Pivot, Trump Backlash Adds Fuel

Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), <a target="_blank" href="https://www.benzinga.com/topic/micron" rel="noreferrer noopener">a memory and storage solutions</a> provider, has seen its stock surge by over 42% year-to-date. This performance significantly outpaces the Nasdaq Composite&#8217;s and S&amp;P 500&#8217;s almost 6% returns.
The strong demand for its memory chips, particularly High-Bandwidth Memory (HBM), specifically HBM3E, has been a key driver. HBM3E is <a target="_blank" href="https://www.benzinga.com/25/03/44394665/microns-hbm3e-and-socamm-products-boost-ai-server-performance-partnering-with-nvidia" rel="noreferrer noopener">crucial for AI accelerators</a> like Graphics Processing Units (GPUs) or Application-Specific Integrated Circuits (ASICs). Micron&#8217;s HBM3E is a component in Nvidia Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) Blackwell and Rubin GPU lines and is also being supplied to other customers for use in GPUs and ASICs.
<h2 class="wp-block-heading">Favorable Market And Policy Environment</h2>
The recovery in the semiconductor market, coupled with efforts by the U.S. government to bolster the domestic semiconductor industry, has boosted chip companies&#8217; valuations. Micron has benefited from a recovery in memory chip pricing and reported increased sales in both data centers and consumer markets.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42657620/amd-and-micron-top-analyst-picks-for-ai-and-next-gen-tech-growth" rel="noreferrer noopener">AMD and Micron Are Top Analyst Picks for AI and Next-Gen Tech Growth</a>
<h2 class="wp-block-heading">Macroeconomic Tailwinds: &#8220;Big Beautiful Bill&#8221; And CHIPS Act</h2>
Recent macro events have further added value to the industry. On July 4, 2025, President Donald Trump announced the &#8220;Big Beautiful Bill,&#8221; which proposes to increase the <a target="_blank" href="https://www.benzinga.com/markets/equities/25/07/46239376/nvidia-intel-broadcom-micron-amd-and-other-chipmakers-stand-to-benefit-as-trumps-tax-bill-increases-incentives-to-make-semiconductors-in-us" rel="noreferrer noopener">semiconductor investment tax credit</a> from 25% to 30% through 2026.
This offers chipmakers an incentive to expand domestic manufacturing facilities. Furthermore, Trump established the United States Investment Accelerator within the Commerce Department via executive order, taking direct control of the CHIPS Act program and shifting its oversight from previous frameworks.
Despite his past criticism of the $39 billion in grants and up to $75 billion in loans under the CHIPS and Science Act, Trump is now promoting pro-chip policies through this new bill, which has passed the Senate and awaits House approval.
<h2 class="wp-block-heading">Micron&#8217;s Strategic U.S. Expansion</h2>
Micron has been pursuing its growth ambitions through substantial investments in the U.S. On June 12, Micron and the Trump Administration <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45906594/micron-and-trump-announce-200-billion-us-chip-expansion-plan-aiming-to-create-90k-jobs" rel="noreferrer noopener">unveiled plans</a> to invest approximately $200 billion in U.S. expansion.
This plan includes the development of two fabs in Idaho, up to four in New York, and the modernization of its existing Virginia plant. An additional $50 billion is earmarked for domestic research and development (R&amp;D) to support Micron&#8217;s leadership in memory technology.
Micron is committed to an extra $30 billion beyond its prior announcements, with new efforts specifically targeting HBM packaging and the construction of a second Dynamic Random Access Memory (DRAM) fab in Boise, Idaho.
This aims to boost production and reduce time to market. The company projects the creation of up to 90,000 direct and indirect jobs and intends to produce 40% of its DRAM in the U.S., co-locating Idaho fabs with R&amp;D operations for operational scale and speed.
Micron is eligible for up to $6.4 billion in CHIPS Act direct funding and Advanced Manufacturing and Innovation Competitiveness (AMIC). It has already finalized a $275 million grant to modernize its Virginia facility and onshore advanced DRAM nodes, crucial for critical sectors such as automotive, defense, and healthcare.
<h2 class="wp-block-heading">Financial Performance</h2>
On June 25, Micron reported <a target="_blank" href="https://www.benzinga.com/markets/earnings/25/06/46104401/micron-q3-earnings-revenue-eps-beat-estimates-data-center-revenue-guidance-ai-demand" rel="noreferrer noopener">third-quarter revenue </a>of $9.3 billion, up roughly 16% on a year-over-year basis, topping the consensus estimate of $8.87 billion. Micron expects fourth-quarter revenue of $10.7 billion, plus or minus $300 million, versus estimates of $9.88 billion. The company said it remains on track to deliver record revenue with solid profitability and free cash flow in fiscal 2025.
<h2 class="wp-block-heading">Potential Risks And Challenges</h2>
However, Micron faces certain risks. Following the quarterly results, Micron CEO Sanjay Mehrotra <a target="_blank" href="https://www.benzinga.com/markets/equities/25/06/46111337/micron-ceo-cautions-ai-boom-may-not-be-fully-sustainable-flags-tariff-driven-demand-pull-in" rel="noreferrer noopener">cautioned that the recent AI-driven demand</a> might not be entirely sustainable, citing potential short-term distortions stemming from global trade tensions.
He warned investors about tariff-related order pull-ins, suggesting that some customers may have accelerated purchases to circumvent potential trade disruptions. While data center growth was strong in the third quarter, Mehrotra advised caution, indicating that the surge could be partly front-loaded and not fully indicative of steady long-term demand.
Bank of America&#8217;s Vivek Arya maintained a<a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/46123124/micron-weak-pc-phone-demand-analyst" rel="noreferrer noopener"> cautious stance</a> on Micron due to ongoing weak demand in the PC and smartphone sectors, which continues to exert pressure on memory chip pricing despite the company&#8217;s earnings and outlook.
On July 8, rival Samsung (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) reported a 56% drop in <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46288786/us-export-bans-and-nvidia-supply-issues-crush-samsung-chip-profits-hopes-rest-on-ultra-thin-foldables-smartwatches-and-possible-xr-debut-at-galaxy-unpacked-event" rel="noreferrer noopener">second-quarter operating profit</a> to 4.6 trillion won (approximately $3.3 billion), falling short of expectations.
Samsung attributed this decline to inventory value adjustments and delays in HBM chip shipments to Nvidia, noting that U.S. export restrictions on AI chips to China heavily impacted its semiconductor business. This marked Samsung&#8217;s weakest profit in six quarters, a decline from 10.4 trillion won a year earlier.
<h2 class="wp-block-heading">Analyst Outlook</h2>
Twenty-six analysts have set a <a target="_blank" href="https://www.benzinga.com/quote/MU/analyst-ratings" rel="noreferrer noopener">consensus price target</a> of $149.77 for Micron. Based on the latest ratings from Baird, Susquehanna, and Stifel, the stock carries an average target of $168.33, suggesting a potential upside of 38.49%.
Price Action: MU stock is trading higher by 1.34% to $121.53 premarket at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/global/25/05/45570606/asml-bets-big-on-high-powered-chip-tools-as-taiwan-semiconductor-intel-micron-line-up" target="_blank" rel="noreferrer noopener">ASML Bets Big On High-Powered Chip Tools As Taiwan Semiconductor, Intel, Micron Line Up</a></li>
</ul>
Image via Shutterstock

Movers

Tech

NVDA

SSNLF

Micron Stock Soars 42% In 2025, But CEO Warns Of Demand Pull-Ins

U.S. stock futures were fluctuating on Tuesday after trimming gains from their records on Monday. Futures of major benchmark indices were trading mixed.
President Donald Trump announced sweeping <a href="https://www.benzinga.com/markets/equities/25/07/46281204/wall-street-today-trump-tariffs-japan-south-korea-stocks-drop">25% tariffs</a> on all imports from Japan and South Korea, and sent letters to a total of 14 countries, all posted on his Truth Social account, starting Aug. 1. 
Japan&#8217;s Prime Minister Shigeru Ishiba has since voiced his <a href="https://www.benzinga.com/markets/economic-data/25/07/46288472/japans-prime-minister-criticizes-trumps-tariff-decision-shigeru-ishiba-calls-move-truly-regrettable">dissatisfaction with Trump's decision</a> to impose 25% tariffs on goods imported from the country, calling it "truly regrettable." 
The 10-year Treasury bond yielded 4.41% and the two-year bond was at 3.90%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 95.3% likelihood of the Federal Reserve keeping the current interest rates unchanged in its July meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.10%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.08%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.21%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.32%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Tuesday. The SPY was up 0.11% at $621.36, while the QQQ advanced 0.26% to $553.47, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
On Monday, consumer staples and utilities stocks defied a broader market downturn, closing higher, while most sectors on the S&amp;P 500 finished in negative territory.
Consumer discretionary, materials, and energy stocks recorded the most significant losses, as U.S. stocks settled lower overall.
In corporate news, Cogent Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COGT#NASDAQ">COGT</a>) announced positive topline results from Part 2 of the SUMMIT trial of bezuclastinib for non-advanced systemic mastocytosis, demonstrating clinically meaningful and statistically significant improvements across primary and all key secondary endpoints.
Conversely, Core Scientific Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) shares experienced a decline of around 18% after CoreWeave revealed its intentions to acquire the company in an all-stock deal.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.92%</td>
<td>20,412.52</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.79%</td>
<td>6,229.98</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.94%</td>
<td>44,406.36</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.55%</td>
<td>2,214.23</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
BlackRock shifted its investment focus from traditional macro anchors to &#8220;mega forces&#8221; like AI, believing these will be &#8220;durable drivers of returns in both the near and long term.&#8221;
This tactical change comes as long-term macro stability wanes, yet the firm sees no need to reduce risk. Instead, they view AI-related investments as a &#8220;new anchor for returns,&#8221; bolstered by &#8220;immutable economic laws&#8221; that limit rapid global change.
This strategy keeps BlackRock &#8220;risk on&#8221; and overweight U.S. equities, anticipating solid corporate earnings despite potential growth dents from tariffs or caution.
Louis Navellier of Navellier &amp; Associates said that tariffs are roiling markets again.
&#8220;Tariffs are back on the front burner as the July 9th deadline is upon us. Rumors abound on pending agreements, along with threats if trading partners aren&#8217;t responsive in a timely fashion. But after the first 90-day delay, expectations are that nothing particularly painful will persist for long, and that the saber rattling will continue,&#8221; he said.
Navellier also highlighted that since the date for actual tariff increases has been pushed to Aug. 1st, &#8220;For now, we&#8217;re seeing some modest hedging taking place today, which isn&#8217;t particularly painful given the recent new all-time highs in stocks.&#8221;
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Tuesday:
<ul class="wp-block-list">
<li>June&#8217;s NFIB optimism index data will be out by 6:00 a.m. ET.</li>
<li>May&#8217;s consumer credit data will be released by 3:00 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>Optical Cable Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCC#NASDAQ">OCC</a>) surged 35.64% after announcing the strategic collaboration with Lightera, including an investment by Lightera resulting in a 7.24% ownership stake in OCC. This partnership aims to expand product offerings and integrated cabling solutions, particularly for the data center and enterprise sectors, with OCC handling sales.</li>
<li>BioSig Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) jumped 27.27% following its merger with Streamex, securing up to $1.1 billion in growth financing to become a major public holder of gold bullion and tokenize the $142 trillion commodities market on the blockchain via Streamex&#8217;s RWA platform powered by Solana.</li>
<li>Thumzup Media Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>) rose 4.12% after completing a registered direct public offering, raising approximately $6.04 million net by selling non-voting Series C Convertible Preferred Stock, with proceeds allocated for general corporate purposes and ad-tech operations.</li>
<li>Helius Medical Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) dropped 10.69% after reports that it plans to sell up to $25 million in common stock.</li>
<li>Penguin Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>) rose 2.01% in premarket on Tuesday as analysts expect it to report earnings of 33 cents per share on the revenue of $328.81 million after the closing bell.</li>
<li>Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) was up 0.23% as it is expected to report earnings after market close. Analysts estimate earnings of 93 cents per share on revenue of $32.29 million.</li>
<li>Kura Sushi USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) advanced 1.62% as analysts expect it to report a quarterly loss of 1 cent per share on revenue of $71.83 million after the closing bell.</li>
<li>Merit Medical Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMSI#NASDAQ">MMSI</a>) gained 0.97% after naming Martha Aronson as President and CEO and said it sees preliminary second-quarter revenue of $380 million to $384 million.</li>
<li>Ascentage Pharma Group International ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPG#NASDAQ">AAPG</a>) was 0.29% above the flatline after naming Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 0.77% to hover around $67.41 per barrel.
Gold Spot US Dollar fell 0.31% to hover around $3,326.03 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was lower by 0.18% at the 97.3020 level.
Asian markets ended higher on Monday as South Korea's Kospi, India's S&amp;P BSE Sensex, Hong Kong's Hang Seng, Australia's ASX 200, Japan's Nikkei 225, and China&#8217;s CSI 300 indices rose. European markets were also higher in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46269226/stocks-just-hit-rare-golden-cross-for-1st-time-since-2023-heres-what-it-means-for-investors">Stocks Just Hit Rare Golden Cross For 1st Time Since 2023 — Here&#8217;s What It Means For Investors</a></li>
</ul>
Photo courtesy: godongphoto / Shutterstock.com

AAPG

BSGM

COGT

Core Scientific, Inc. - Class A Common Stock

CORZ

HSDT

KRUS

MMSI

Penguin Solutions, Inc. - Ordinary Shares

PENG

TZUP

US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns'

The National Highway Traffic Safety Administration (NHTSA) has launched an investigation into the recall of close to 1.2 million RAM pickup trucks after the agency reviewed multiple incidents, which caused 7 injuries and 12 incidents involving fire or crash, questioning whether Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) failed to address the issue.
What Happened: The issue stems from the trucks disengaging from the Park setting on the transmission and rolling away unexpectedly despite there being no key in the ignition or the foot being taken off the brake pedal, the agency said in a report on Monday.
The issue affects RAM pickup trucks manufactured between 2013-2018, including the RAM 1500, 2500, 3500, 4500, and 5500 Pickup trucks. The report suggests that 1,187,232 trucks could be affected by the issue.
<figure class="wp-block-image aligncenter size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="994" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08060618/NHTSA-Stellantis-1024x994.jpg" alt="" class="wp-image-976205" style="width:466px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08060618/NHTSA-Stellantis-1024x994.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08060618/NHTSA-Stellantis-300x291.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08060618/NHTSA-Stellantis-768x746.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08060618/NHTSA-Stellantis.jpg 1299w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Source: NHTSA
Why It Matters: The news comes as the Detroit-based manufacturer had issued a separate recall for over 299k vehicles, relating to an issue with the <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46220764/stellantis-under-new-federal-recall-investigation-for-gear-shifter-issue">shifter cable bushings</a> in the 2013-2016 Dodge Dart.
Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) has had to issue <a href="https://www.benzinga.com/markets/tech/25/06/46068633/ford-recalls-aviator-suvs-as-adhesive-issue-adds-to-automakers-mounting-recall-woes">multiple recalls</a> for various issues related to its vehicles.
Elsewhere, Stellantis had conducted trials of a new <a href="https://www.benzinga.com/markets/tech/25/06/45945138/stellantis-trials-new-5-minute-battery-swapping-tech-in-fiat-500e-fleet-report">5-minute battery-swapping</a> technology in the Spanish capital Madrid with a fleet of over 40 Fiat 500e vehicles in collaboration with battery-swapping company Ample.
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46289556/trumps-tax-bill-axes-the-7500-ev-credit-heres-how-you-can-still-claim-it">Trump&#8217;s Tax Bill Axes The $7,500 EV Credit: Here&#8217;s How You Can Still Claim It</a></li>
</ul>
Photo courtesy: Jonathan Weiss / Shutterstock.com

STLA

NHTSA Launches Probe Into Stellantis-Owned RAM Pickup Truck Recall After Reports Of Injuries

NAMI

Jinxin Technology CFO Huazhen Xu Resigns For Personal Reasons Effective Immediately; COO Jun Jiang Appointed Interim CFO Pending Permanent Successor

Shares of ENDRA Life Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) rose sharply in pre-market trading after the company announced it will be granted a US patent titled &#8220;<a href="https://www.benzinga.com/quote/NDRA">Radio Frequency Applicator&#8221;.</a>
ENDRA Life Sciences shares jumped 61.4% to $5.58 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Bolt Projects Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSLK#NASDAQ">BSLK</a>) surged 71.8% to $4.36 in pre-market trading.</li>
<li>Optical Cable Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCC#NASDAQ">OCC</a>) climbed 44.2% to $5.22 in pre-market trading after the company entered into a strategic collaboration agreement with Lightera to expand offerings for data center and enterprise.</li>
<li>IT Tech Packaging, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITP#NYSE">ITP</a>) rose 40.1% to $0.2601 in pre-market trading.</li>
<li>BioSig Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) jumped 27.3% to $14.70 in pre-market trading. BioSig and Streamex announced up to $1.1 billion in growth financing to launch gold-backed treasury strategy and RWA tokenization platform.</li>
<li>Viomi Technology Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIOT#NASDAQ">VIOT</a>) gained 20.8% to $3.19 in pre-market trading after jumping 59% on Monday.</li>
<li>Globavend Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) gained 19.6% to $0.0975 in pre-market trading after gaining 8% on Monday.</li>
<li>The Chemours Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>) gained 18.5% to $14.70 in pre-market trading.</li>
<li>Wolfspeed, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) gained 13.7% to $2.66 in pre-market trading. Wolfspeed shares jumped 96% on Monday after the company announced it appointed Gregor van Issum As CFO.</li>
<li>Vor Biopharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) gained 12.4% to $3.00 in pre-market trading after jumping 40% on Monday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Blue Gold Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGL#NASDAQ">BGL</a>) dipped 15.6% to $63.00 in pre-market trading after dipping 30% on Monday.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMN#NASDAQ">PMN</a>) shares tumbled 14.3% to $0.3507 in pre-market trading after falling over 5% on Monday.</li>
<li>LogProstyle Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGPS#NYSE">LGPS</a>) fell 14.3% to $1.45 in pre-market trading after gaining around 108% on Monday.</li>
<li>La Rosa Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRHC#NASDAQ">LRHC</a>) dipped 12.2% to $7.37 in pre-market trading after dipping 30% on Monday.</li>
<li>Helius Medical Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) fell 10.9% to $8.42 in pre-market trading. Helius Medical Technologies filed prospectus for $25 million share offering.</li>
<li>ProPhase Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) fell 10.4% to $0.3961 in pre-market trading after gaining more than 5% on Monday.</li>
<li>MediaCo Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDIA#NASDAQ">MDIA</a>) declined 10.2% to $1.23 in pre-market trading after gaining 25% on Monday.</li>
<li>Pelthos Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTHS#NASDAQ">PTHS</a>) declined 8.3% to $23.79 in pre-market trading after gaining 60% on Monday.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) shares fell 5.1% to $25.08 in pre-market trading after declining 4% on Monday.</li>
<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) fell 4.8% to $10.58 in pre-market trading after gaining more than 5% on Monday.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46289573/trump-tariffs-sink-dow-over-400-points-investor-sentiment-declines-but-fear-greed-index-remains-in-extreme-greed-zone">Trump Tariffs Sink Dow Over 400 Points: Investor Sentiment Declines, But Fear &amp; Greed Index Remains In &#8216;Extreme Greed&#8217; Zone</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Trading Ideas

BSLK

LGPS

LRHC

MDIA

NDRA

PRPH

PTHS

SEDG

VIOT

WOLF

Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket

IVP Inspire Veterinary Partners Inc Files SEC Prospectus for Up to 3.3M Units Offering

SQNS

Sequans (NYSE:SQNS) Closes $384M Strategic Investment To Launch Bitcoin Treasury Initiative, With $195M PIPE And $189M In Convertible Debentures

Organigram Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/OGI#TSX">OGI</a>), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today that its recently acquired beverage business, Collective Project, has launched an e-commerce platform in the U.S. marking a key milestone in the Company's strategic expansion into the rapidly evolving U.S. hemp-derived THC beverage market. The launch also includes a bold new portfolio of hemp-derived THC beverages designed to meet diverse consumer preferences.
&nbsp;
In response to consumer demand for accessible, high-quality THC beverages, the Company's e-commerce platform at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcollectiveproject.com&amp;esheet=54287037&amp;newsitemid=20250708060367&amp;lan=en-US&amp;anchor=https%3A%2F%2Fcollectiveproject.com&amp;index=1&amp;md5=df1f46f214f5809d8b5213d5ec5ffd28">https://collectiveproject.com</a> expands U.S. consumer access to these products across 25 states. The launch represents a milestone in Organigram's multi-phase U.S. expansion strategy, enhancing the Company's presence in a category experiencing growth. The hemp-derived THC beverage market in the U.S. has already surpassed $1 billion in retail sales and is projected to reach $4 billion by 20281.
The platform launches with an expanded and diverse line of products for every occasion, including Sparkling Juices and Sparkling Lemonades. Available in multiple pack sizes and THC dosages, the beverages are designed to cater to a range of preferences and experience levels, from curious newcomers to seasoned connoisseurs. The second phase of the launch will include Fetch, a new line of bold hemp-derived THC sodas set to launch later this summer, with details to be announced.

TSX:OGI

Canadian Cannabis Brand Organigram Launches THC Drinks Online in 25 US States, Expands Into $1B US THC Beverage Market With New E-Commerce Rollout

Concentra will acquire CARGO for $4.379 in cash per share of CARGO common stock, par value $0.001 per share ("CARGO Common Stock"), plus one non-transferable contingent value right ("CVR"), which represents the right to receive:
&nbsp;(i) 100% of the closing net cash of CARGO in excess of $217.5 million; and&nbsp;
(ii) 80% of any net proceeds received within two years following closing from any disposition of certain of CARGO's product candidates that occurs within two years following closing, each pursuant to a contingent value rights agreement

CRGX

Concentra Biosciences To Acquire CARGO Therapeutics For $4.379 Cash Per Share Plus Contingent Value Right, Deal Expected To Close August 2025

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4463195-1&amp;h=2715295146&amp;u=https%3A%2F%2Fwww.sojern.com%2F&amp;a=Sojern">Sojern</a>, the leading marketing platform built for hospitality, is joining forces with <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4463195-1&amp;h=296508193&amp;u=https%3A%2F%2Fpubmatic.com%2F&amp;a=PubMatic">PubMatic</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PUBM#NASDAQ">PUBM</a>), an independent technology company shaping the future of digital advertising's supply chain. This new relationship enables agencies and advertisers to access and activate Sojern's extensive real-time travel data insights, with PubMatic's premium inventory, to target travelers more accurately and in a privacy-compliant way.
&nbsp;
Creating personalized, targeted campaigns requires finding the right mix of audiences and inventory supply. Curation is a preferred option, enabling real-time optimization and measurement so brands can create relevant ads that drive results. By using a <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4463195-1&amp;h=2193176365&amp;u=http%3A%2F%2Fsojern.com%2Fblog%2Fwhat-googles-latest-third-party-cookie-news-means-for-travel-marketers--and-why-were-ready&amp;a=multi-ID+approach">multi-ID approach</a>, curation enables advertisers to work directly with supply-side platforms (SSPs) to strategically combine first-party data, Sojern travel segments, and premium inventory.

PUBM

Sojern Teams Up With PubMatic to Deliver Smarter Travel Ads With Real-Time Data

Craig Shapiro, a macro strategist at The Bear Traps Report, says that President Donald Trump&#8217;s approach to inflation management is not that unlike &#8220;running a protection racket,&#8221; one that is built on coercion and intimidation, rather than the use of monetary tools.
What Happened: &#8220;Trump isn't fighting inflation with traditional tools,&#8221; Shapiro said on Monday, in a post on X, adding that &#8220;He's managing it like a boss running a protection racket.&#8221;
According to Shapiro, Trump&#8217;s strategy hinges on behavioral enforcement via public shaming, regulatory threats, and backroom pressure tactics to influence corporate pricing behavior, instead of fiscal and monetary controls.
See Also: <a href="https://www.benzinga.com/markets/forex/25/07/46272823/as-us-dollar-sinks-top-economist-warns-10-slide-could-spark-new-inflation-spike">As US Dollar Sinks, Top Economist Warns 10% Slide Could Spark New Inflation Spike</a>
He cites several examples of this, starting with his <a href="https://www.benzinga.com/news/25/05/45530157/peter-schiff-slams-trumps-eat-the-tariffs-message-to-walmart-he-might-as-well-ask-it-to-eat-rent-wag">&#8220;eat the tariffs&#8221; remark</a> to Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), <a href="https://www.benzinga.com/markets/tech/25/06/45769527/trump-threatened-tariffs-on-apple-and-mattel-why-the-barbie-maker-could-slide-free-but-tim-cooks-com">the tariffs threat</a> to Mattel Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>) and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), and so much more. 
Shapiro calls this model &#8220;Protection Racket Capitalism,&#8221; where major corporations like Walmart, Apple, and Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) play the role of capos expected to enforce price discipline in their respective sectors. &#8220;Maintain discipline in your territory, or else,&#8221; he says.
&#8220;Meanwhile,&#8221; he says, Trump is using other policy tools, such as running deficits, imposing tariffs and pursuing deregulation, all of which he says are inflationary, while the &#8220;narrative is being held together by intimidation.&#8221;
The biggest vulnerability, according to Shapiro, is structural inflation. &#8220;You can jawbone Walmart,&#8221; he says. &#8220;You can threaten refiners. But you can't jawbone the rent.&#8221;
In conclusion, he states that if core inflation metrics were to reaccelerate in late-2025, this entire &#8220;Boss Economy&#8221; model could unravel, revealing a fragile narrative being held together, not by policy strength, but by optics and intimidation. 
<figure class="wp-block-embed aligncenter is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Trump isn't fighting inflation with traditional tools. He's managing it like a boss running a protection racket. Welcome to the Boss Economy: a world where prices are controlled by fear, favor, and direct intervention from the top. &#x1f9f5;
&mdash; Craig Shapiro (@ces921) <a href="https://twitter.com/ces921/status/1942192955885773235?ref_src=twsrc%5Etfw">July 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: This is precisely what Economist Peter Schiff had warned several months ago when Trump had asked Walmart to &#8220;eat the tariffs&#8221; and not pass on the costs to consumers. 
&#8220;Trump said Walmart should eat the tariffs. He might as well tell Walmart to <a href="https://www.benzinga.com/news/25/05/45530157/peter-schiff-slams-trumps-eat-the-tariffs-message-to-walmart-he-might-as-well-ask-it-to-eat-rent-wag">eat its rent</a>, wages, insurance, utilities, and all of its other costs too,&#8221; Schiff said.
Besides this, Yardeni Research President&nbsp;Ed Yardeni, believes that Trump&#8217;s tariffs have not been inflationary thus far, because falling oil and goods prices are <a href="https://www.benzinga.com/government/regulations/25/04/44828850/trump-tariffs-may-not-ignite-inflation-after-all-says-yardeni?">providing a deflationary backdrop</a>. 
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/asia/25/07/46290263/is-china-dodging-us-tariffs-direct-exports-to-america-plunge-43-as-vietnam-and-indonesia-see-big-spurts-report">Is China Dodging US Tariffs? Direct Exports To America Plunge 43% As Vietnam And Indonesia See Big Spurts: Report</a></li>
</ul>
Photo courtesy: Rawpixel.com / Shutterstock.com

AAPL

Trump Manages Inflation Like 'Boss Running A Protection Racket,' Says Craig Shapiro: 'You Can Jawbone Walmart, But Not The Rent'

Parsons Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSN#NYSE">PSN</a>) announced today that the company has been appointed as the Project Management Consultant on the Dubai Metro Blue Line project by the government of Dubai's Roads and Transport Authority (RTA). The contract represents new work for Parsons and spans five years.
Under the contract, Parsons will provide comprehensive project management services including design review, procurement support, construction supervision, testing and commissioning oversight, and project handover management. The Dubai Metro Blue Line, expected to commence operations in 2029, is a key component of Dubai's D33 Economic Agenda, which aims to position Dubai among the world's fastest, safest, and most connected cities by 2033.

Parsons Lands 5-Year Deal to Oversee Dubai's New Metro Line, Boosting Global Footprint

RMTI

Rockwell Medical Signs Multi-Year, Multi-Million Dollar Deal With Innovative Renal Care To Supply Hemodialysis Concentrates Across US Clinics

SHEN

Shenandoah Telecommunications Expands Glo Fiber FTTH To 2,600 More Homes In Frederick County, MD, Bringing 5 Gbps Service To Walkersville And New Market By 2026 At Straightforward Pricing

Aurora Mobile Expands Stablecoin Use Cases In SaaS, Content, And Advertising With HashNut-Powered Web3 Payments

Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) strengthened its partnership with OpenAI after the ChatGPT maker confirmed it has no plans to deploy Alphabet Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) in-house artificial intelligence chips at scale, despite recent cloud collaboration between the rivals.
What Happened: &#8220;We&#8217;re proud to partner with OpenAI and continue powering the foundation of their work,&#8221; Nvidia wrote on X Monday, citing a Reuters report that OpenAI rejected Google&#8217;s tensor processing units (TPUs) for large-scale deployment.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We're proud to partner with <a href="https://twitter.com/OpenAI?ref_src=twsrc%5Etfw">@OpenAI</a> and continue powering the foundation of their work. <a href="https://t.co/CWgsn1uAIk">pic.twitter.com/CWgsn1uAIk</a>
&mdash; NVIDIA (@nvidia) <a href="https://twitter.com/nvidia/status/1942270425607569562?ref_src=twsrc%5Etfw">July 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
OpenAI spokesperson confirmed to Reuters on Sunday that the AI lab is conducting early testing with some Google TPUs but has no active plans to use them at scale. The company continues relying on Nvidia&#8217;s graphics processing units (GPUs) and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) AI chips to meet growing computational demands.
The statement comes two days after Reuters reported OpenAI signed a cloud services deal with Google Cloud in May, marking a rare partnership between direct AI competitors. 
See Also: <a href="https://www.benzinga.com/markets/hedge-funds/25/07/46290114/bill-ackman-bets-over-60-of-pershing-squares-portfolio-in-these-4-stocks-uber-hhh-and-more">Bill Ackman Bets Over 60% Of Pershing Square&#8217;s Portfolio In These 4 Stocks: UBER, HHH And More</a>
Why It Matters: The agreement provides OpenAI access to Google&#8217;s <a href="https://www.benzinga.com/news/23/05/32645037/nvidia-vulnerable-to-in-house-ai-chip-production-by-google-meta-microsoft-amazon">infrastructure to support training and deployment</a> of models like ChatGPT, reducing reliance on Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Azure.
Google has expanded external availability of its TPUs, historically reserved for internal use, winning customers including Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and AI startups Anthropic and Safe Superintelligence. The <a href="https://www.benzinga.com/markets/equities/24/10/41615800/googles-cost-advantage-with-custom-chips-only-nvidia-tops-it-says-analyst">custom chips offer Google a cost advantage</a> second only to Nvidia in performance, according to D.A. Davidson analyst Gil Luria.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/biotech/25/07/46289610/palantir-co-founder-joe-lonsdale-wants-a-fda-overhaul-with-special-forces-style-ai-team-because-china-is-racing-to-outpace-us-in-biotech">Palantir Co-Founder Joe Lonsdale Wants A FDA Overhaul With Special Forces-Style AI Team Because China Is Racing To Outpace US In Biotech</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Jack Hong / Shutterstock.com

CRWV

GOOG

GOOGL

MSFT

OpenAI Sticks With Nvidia: ChatGPT Maker Says No Plans To Use Google's AI Chips At Scale

In the wake of&nbsp;Elon Musk&#8216;s political aspirations, traders who bet against&nbsp;Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) are projected to earn approximately $1.4 billion due to a resultant drop in the company&#8217;s stock.
What Happened: Elon Musk's plan to launch a new U.S. political party has sparked doubts about his focus on Tesla's future. Coupled with his ongoing public clash with President Donald Trump over the tax-cut and spending bill, this led to nearly a 7% drop in Tesla's shares during early trading on Monday, according to a Reuters. 
With the shares valued at $296, those who bet against the electric vehicle maker are poised to make around $1.4 billion, according to data from analytics firm Ortex. This follows a $4 billion profit made by short sellers on June 5, after Tesla&#8217;s largest single-day market value drop, also due to the Musk-Trump social media spat.
By the close of trading, Tesla&#8217;s shares had dropped 6.8% to $293.94, marking a total loss of 22.5% year-to-date.
SEE ALSO: <a href="https://benzinga.com/markets/tech/25/07/46288500/elon-musk-may-be-callous-insensitive-and-extremely-cruel-but-black-swan-author-nassim-taleb-is-prayi" target="_blank" rel="noreferrer noopener">Elon Musk May Be Callous, Insensitive And &#8216;Extremely Cruel&#8217; But &#8216;Black Swan&#8217; Author Nassim Taleb Is Praying For His Safety Amid Rift With Trump</a>
Why It Matters: Musk&#8217;s political ambitions have been a point of concern for investors, with some suggesting that the lack of an<a href="https://www.benzinga.com/markets/tech/25/07/46273662/no-plan-b-teslas-musk-premium-is-on-thin-ice"> alternative CEO </a>could be detrimental to Tesla&#8217;s future. The company&#8217;s shares have been on a downward trajectory, with profits and deliveries hitting multi-quarter lows, leading to investor unease.
Notably, veteran investors and analysts, including Ross Gerber and Dan Ives, have criticized Musk&#8217;s return to politics and questioned the Tesla Board of Directors as the company&#8217;s stock was <a href="https://www.benzinga.com/markets/tech/25/07/46288776/ross-gerber-slams-joke-tesla-board-as-elon-musk-returns-to-politics-dan-ives-says-musk-cannot-start-own-political-party-and-remain-ceo">on a declining</a> spree on Monday.
President Donald Trump has also expressed<a href="https://www.benzinga.com/news/politics/25/07/46266957/trump-calls-america-party-a-train-wreck-blasts-elon-musk-for-going-completely-off-the-rails-president-says-system-not-designed-for-a-third-player"> his discontent </a>with Musk&#8217;s political plans, describing them as a &#8220;train wreck&#8221; and suggesting that the U.S. system is not designed for third-party disruption.
<ul class="wp-block-list">
<li>READ MORE: <a href="https://www.benzinga.com/news/politics/25/07/46290046/beijing-rejects-elon-musk-as-a-geopolitical-asset-lukewarm-response-to-chinese-diplomatic-overreach-trump-feud-reportedly-diminishes-musks-value">Beijing Rejects Elon Musk As A &#8216;Geopolitical Asset&#8217;: Lukewarm Response To Chinese Diplomatic Overreach, Trump Feud Reportedly Diminishes Musk&#8217;s Value</a> </li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tesla Short Sellers To Earn Nearly $1.4 Billion In Profits Amid Elon Musk's Political Ambitions: Report

Press Releases

"Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances"

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Cardiol Therapeutics Announces Year-End 2024 Update on Operations

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders

Comments

Cardiol Therapeutics

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL